肿瘤微环境
蛋白酵素
抗体
抗原
癌症研究
癌症
治疗方式
单克隆抗体
计算生物学
生物
医学
免疫学
肿瘤细胞
酶
生物化学
内科学
作者
Yutong Liu,Annalee W. Nguyen,Jennifer A. Maynard
标识
DOI:10.1016/j.copbio.2022.102809
摘要
Antibody-based therapeutics enjoy considerable clinical and commercial successes as cancer treatments. However, they can also cause serious toxicities due to recognition of tumor-associated antigens in noncancerous tissues, which can prevent antibody use in certain patient populations and therapeutic modalities. Here, we discuss recent efforts to develop advanced antibody therapeutics with activities restricted to the solid tumor microenvironment. With the intent of decreasing toxicities and expanding therapeutic windows, protein engineering strategies can render ligand binding sensitive to multiple tumor-specific characteristics. These triggers can be intrinsic to solid tumor microenvironments, such as low pH, high extracellular ATP, and the presence of specific proteases. Emerging strategies rely instead on exogenous triggers such as light and ultrasound to provide spatial and temporal control over antibody activation. These multilayered approaches to targeting diseased tissues are expected to usher in a new generation of precision therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI